JP2012526793A5 - - Google Patents

Download PDF

Info

Publication number
JP2012526793A5
JP2012526793A5 JP2012510375A JP2012510375A JP2012526793A5 JP 2012526793 A5 JP2012526793 A5 JP 2012526793A5 JP 2012510375 A JP2012510375 A JP 2012510375A JP 2012510375 A JP2012510375 A JP 2012510375A JP 2012526793 A5 JP2012526793 A5 JP 2012526793A5
Authority
JP
Japan
Prior art keywords
compound
group
alkyl
substituted
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012510375A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012526793A (ja
Filing date
Publication date
Priority claimed from GB0908338A external-priority patent/GB0908338D0/en
Priority claimed from GBGB1006112.5A external-priority patent/GB201006112D0/en
Application filed filed Critical
Priority claimed from PCT/GB2010/050797 external-priority patent/WO2010131054A1/en
Publication of JP2012526793A publication Critical patent/JP2012526793A/ja
Publication of JP2012526793A5 publication Critical patent/JP2012526793A5/ja
Pending legal-status Critical Current

Links

JP2012510375A 2009-05-15 2010-05-17 酸化還元薬物誘導体 Pending JP2012526793A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0908338.7 2009-05-15
GB0908338A GB0908338D0 (en) 2009-05-15 2009-05-15 Redox drug derivatives
GBGB1006112.5A GB201006112D0 (en) 2010-04-13 2010-04-13 Redox drug derivatives
GB1006112.5 2010-04-13
PCT/GB2010/050797 WO2010131054A1 (en) 2009-05-15 2010-05-17 Redox drug derivatives

Publications (2)

Publication Number Publication Date
JP2012526793A JP2012526793A (ja) 2012-11-01
JP2012526793A5 true JP2012526793A5 (https=) 2013-07-18

Family

ID=42304532

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012510375A Pending JP2012526793A (ja) 2009-05-15 2010-05-17 酸化還元薬物誘導体

Country Status (15)

Country Link
US (1) US8877945B2 (https=)
EP (1) EP2429991B1 (https=)
JP (1) JP2012526793A (https=)
KR (1) KR20120025519A (https=)
CN (1) CN102459169B (https=)
AU (1) AU2010247141A1 (https=)
BR (1) BRPI1010981A2 (https=)
CA (1) CA2762022A1 (https=)
EA (1) EA201101564A1 (https=)
IL (1) IL216214A (https=)
MX (1) MX2011012134A (https=)
NZ (2) NZ596492A (https=)
SG (1) SG176056A1 (https=)
WO (1) WO2010131054A1 (https=)
ZA (1) ZA201108276B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2496972A (en) * 2011-11-18 2013-05-29 Redx Pharma Ltd Oxime and hydrazone derivatives of fluoroquinolone antibacterial drugs
WO2013093458A2 (en) * 2011-12-21 2013-06-27 Redx Pharma Limited Antiviral drug derivatives
CN102827187B (zh) * 2012-07-18 2014-05-14 河南大学 氟喹诺酮醛缩异烟腙及其制备方法和应用
US9499554B2 (en) 2013-05-14 2016-11-22 Biocryst Pharmaceuticals, Inc. Anti-influenza compositions and methods

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE444566B (sv) 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
CA1175836A (en) 1977-09-20 1984-10-09 Marcel Pesson Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives
JPS5746986A (en) 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
DE3333719A1 (de) 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
JPH0635458B2 (ja) 1985-02-15 1994-05-11 大日本製薬株式会社 ピリドンカルボン酸誘導体、そのエステルおよびその塩
NO166131C (no) 1985-06-20 1991-06-05 Daiichi Seiyaku Co Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.
DE3881939T2 (de) 1987-02-26 1993-09-30 Daiichi Seiyaku Co Verwendung von Ofloxacin zur lokalen Behandlung oder Prophylaxe von Beschwerden der Wurzelhaut der Zähne.
JPH07113026B2 (ja) * 1988-06-01 1995-12-06 ダイセル化学工業株式会社 オフロキサシンのエステル類の光学分割方法
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
JP2777661B2 (ja) 1988-10-20 1998-07-23 大塚製薬株式会社 ベンゾヘテロ環化合物
GB8906166D0 (en) 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
CZ288492B6 (en) 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
FI96313C (fi) 1990-11-28 1996-06-10 Daiichi Seiyaku Co Menetelmä terapeuttisesti käyttökelpoisten ja optisesti aktiivisten 10-(3-amino-4,4-dialkyyli-1-pyrrolidinyyli)-9-fluori-2,3-dihydro-3(S)-metyyli-7-okso-7H-pyrido/1,2,3-de//1,4/bentsoksatsiini-6-karboksyylihappojen valmistamiseksi
CA2081068C (en) 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
DE4200414A1 (de) 1992-01-10 1993-07-15 Bayer Ag Chinolon- und naphthyridon-carbonsaeure-derivate
NO304832B1 (no) 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
AU673824B2 (en) 1992-05-29 1996-11-28 Bayer Aktiengesellschaft Cyclopentane- and -pentene-beta-amino acids
US5235054A (en) 1992-07-15 1993-08-10 Pfizer Inc. 3-carboxaldehyde substituted quinolines and naphthyridines
DE4234078A1 (de) 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
NO301165B1 (no) 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicykliske aminderivater og antibakterielle midler inneholdende disse
US5527910A (en) 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
DE4301246A1 (de) 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
TW301607B (https=) 1993-03-09 1997-04-01 Takeda Pharm Industry Co Ltd
US5665754A (en) 1993-09-20 1997-09-09 Glaxo Wellcome Inc. Substituted pyrrolidines
BR9607098B8 (pt) 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
DE19546249A1 (de) 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
US5763483A (en) 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
ATE228130T1 (de) 1996-02-23 2002-12-15 Bayer Ag Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0)-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3- hinolincarbonsäuren und ihre derivate
ATE211468T1 (de) 1996-07-22 2002-01-15 Sankyo Co Neuraminsäuredervate, ihre herstellung und medizinische verwendung
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
IL126999A (en) 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
NZ335368A (en) 1996-11-14 2001-08-31 Biota Scient Management Macromolecular compound with one or more neuraminidase binders, binds to the active site of influenza virus neuraminidase
US6127418A (en) 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
TW477783B (en) 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
CA2315262C (en) 1997-12-17 2009-11-10 Biocryst Pharmaceuticals, Inc. Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
HN1999000174A (es) 1998-10-30 1999-10-13 Bayer Ag Formulacion medicamentosa acuisa para administracion oral.
DE19941217A1 (de) 1999-08-30 2001-03-15 Asta Medica Ag Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben
CN1312131C (zh) 2000-02-09 2007-04-25 第一制药株式会社 包含作为活性成分的吡啶酮羧酸的抗耐酸细菌药
JP2004099494A (ja) 2002-09-09 2004-04-02 Shiono Chemical Co Ltd 光学活性三環式化合物の製造方法
ATE423117T1 (de) 2003-09-22 2009-03-15 Janssen Pharmaceutica Nv Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone
CN101010077A (zh) 2004-06-23 2007-08-01 罗伯特·F·霍夫曼 靶向的氧化性治疗制剂在烧伤治疗中的用途
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
EP2017273A1 (en) 2007-07-18 2009-01-21 Laboratorios del Dr. Esteve S.A. Process for the enantioselective preparation of pregabalin
JP5509080B2 (ja) 2007-08-31 2014-06-04 アカデミア シニカ 抗インフルエンザ活性を有するオセルタミビル含有ホスホネートコンジナーの合成
EP2053040A1 (en) 2007-10-26 2009-04-29 Chemo Ibérica, S.A. Pregabalin intermediates and process for preparing them and Pregabalin

Similar Documents

Publication Publication Date Title
JP2015505296A5 (https=)
JP2016506960A5 (https=)
JP2016505512A5 (https=)
JP2014508804A5 (https=)
JP2016528301A5 (https=)
JP2013518107A5 (https=)
JP2017533968A5 (https=)
JP2015500843A5 (https=)
JP2016530259A5 (https=)
JP2015512931A5 (https=)
JP2013507423A5 (https=)
JP2017531038A5 (https=)
JP2011246469A5 (https=)
JP2016534063A5 (https=)
JP2017537066A5 (https=)
JP2015508103A5 (https=)
JP2018524390A5 (https=)
JP2012092103A5 (https=)
JP2013537203A5 (https=)
JP2011529054A5 (https=)
JP2020507589A5 (https=)
JP2020097577A5 (https=)
JP2011518833A5 (https=)
JP2011528658A5 (https=)
JP2016040288A5 (https=)